Moreover, CH has shown to inhibit hypoxia-driven progression of vasculogenic mimicry during angiogenesis, which is a common characteristic feature observed in tumour microenvironments by reducing the expression of HIF-1α, SPHK-1 and phospho-Akt/GSK-3β signaling in cancer cells [30]. This evidence concerns the gene GSK3B and neoplasm.